Portfolio holdings of Dodge & Cox. Dodge & Cox stock picks:. Stock Holdings page.
Dodge & Cox
i
Website
OBJECTIVES
The Fund seeks long-term growth of principal and income. A secondary objective is to achieve a reasonable current income.
STRATEGY
The Fund invests primarily in a broadly diversified portfolio of common stocks. In selecting investments, the Fund invests in companies that, in Dodge & Cox’s opinion, appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth. The Fund focuses on the underlying financial condition and prospects of individual companies, including future earnings, cash flow and dividends. Various other factors, including financial strength, economic condition, competitive advantage, quality of the business franchise and the reputation, experience and competence of a company's management are weighed against valuation in selecting individual securities.
Long-Term Approach
Decades of investing have taught us that the perception of an investment’s worth fluctuates much more widely than its underlying fundamentals. We are skeptical that short-term market trends can be predicted with consistency, so we look further out in our analysis, focusing on the key fundamental factors that will determine investment value over the long-term. As our view diverges from the consensus, we find investment opportunities.
We continually focus on the long-term by asking ourselves the hypothetical question: based on what we know now, how would we invest an “all-cash” portfolio today assuming we could not trade for the next three to five years? This framework forces us to reevaluate our portfolio holdings within an ever-changing market environment, and to reaffirm our rationale for each investment’s long-term value.
Strict Price Discipline
From the earliest days, Dodge & Cox’s investment approach has stressed evaluation of risk relative to opportunity. A strict price discipline — steering clear of popular choices that come at a price premium we would rather not pay — is critical to achieving our investment objectives. Low valuation investments, for example, typically reflect low investor expectations that may serve as a buffer against the risk of significant price decline; these low expectations may also create greater potential for capital appreciation should investor pessimism turn out to be unwarranted or short-lived. At all times, our ongoing search for superior relative value is guided by a rigorous research process that seeks to differentiate the short-term concerns that may be temporarily depressing an investment from the intractable, long-term problems that could doom it.
OBJECTIVES
The Fund seeks long-term growth of principal and income. A secondary objective is to achieve a reasonable current income.
STRATEGY
The Fund invests primarily in a broadly diversified portfolio of common stocks. In selecting investments, the Fund invests in companies that, in Dodge & Cox’s opinion, appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth. The Fund focuses on the underlying financial condition and prospects of individual companies, including future earnings, cash flow and dividends. Various other factors, including financial strength, economic condition, competitive advantage, quality of the business franchise and the reputation, experience and competence of a company's management are weighed against valuation in selecting individual securities.
Long-Term Approach
Decades of investing have taught us that the perception of an investment’s worth fluctuates much more widely than its underlying fundamentals. We are skeptical that short-term market trends can be predicted with consistency, so we look further out in our analysis, focusing on the key fundamental factors that will determine investment value over the long-term. As our view diverges from the consensus, we find investment opportunities.
We continually focus on the long-term by asking ourselves the hypothetical question: based on what we know now, how would we invest an “all-cash” portfolio today assuming we could not trade for the next three to five years? This framework forces us to reevaluate our portfolio holdings within an ever-changing market environment, and to reaffirm our rationale for each investment’s long-term value.
Strict Price Discipline
From the earliest days, Dodge & Cox’s investment approach has stressed evaluation of risk relative to opportunity. A strict price discipline — steering clear of popular choices that come at a price premium we would rather not pay — is critical to achieving our investment objectives. Low valuation investments, for example, typically reflect low investor expectations that may serve as a buffer against the risk of significant price decline; these low expectations may also create greater potential for capital appreciation should investor pessimism turn out to be unwarranted or short-lived. At all times, our ongoing search for superior relative value is guided by a rigorous research process that seeks to differentiate the short-term concerns that may be temporarily depressing an investment from the intractable, long-term problems that could doom it.
Period: Q4 2024
Portfolio date: 31 Dec 2024
No. of stocks: 79
Portfolio value: $109,610,608,000
History | Stock | % of Portfolio |
RecentActivity | Shares | ReportedPrice* | Value | Current Price |
+/-Reported Price |
52Week Low |
52Week High |
|
≡ | FI - Fiserv Inc. | 4.11 | Reduce 0.10% | 21,912,300 | $205.42 | $4,501,225,000 | $216.13 | 5.21% | $145.98 | $238.59 | |
≡ | SCHW - Charles Schwab Corp. | 4.07 | Reduce 0.10% | 60,285,735 | $74.01 | $4,461,747,000 | $77.81 | 5.13% | $60.36 | $84.22 | |
≡ | WFC - Wells Fargo | 3.29 | Reduce 18.12% | 51,306,541 | $70.24 | $3,603,771,000 | $70.69 | 0.64% | $49.24 | $81.30 | |
≡ | RTX - RTX Corp. | 3.22 | Reduce 0.10% | 30,465,400 | $115.72 | $3,525,456,000 | $131.72 | 13.83% | $94.95 | $136.17 | |
≡ | MET - MetLife Inc. | 2.97 | Reduce 0.10% | 39,740,342 | $81.88 | $3,253,939,000 | $79.23 | -3.24% | $65.87 | $88.48 | |
≡ | JCI - Johnson Controls Intl. plc | 2.88 | Reduce 4.35% | 39,932,517 | $78.93 | $3,151,874,000 | $79.69 | 0.96% | $58.68 | $90.73 | |
≡ | SNY - Sanofi Aventis | 2.52 | Reduce 1.47% | 57,357,524 | $48.23 | $2,766,353,000 | $55.82 | 15.74% | $43.38 | $60.12 | |
≡ | FDX - FedEx Corp. | 2.37 | Add 5.31% | 9,230,077 | $281.33 | $2,596,698,000 | $241.71 | -14.08% | $217.22 | $309.09 | |
≡ | CHTR - Charter Communications | 2.33 | Reduce 0.10% | 7,455,376 | $342.77 | $2,555,479,000 | $369.02 | 7.66% | $236.08 | $415.27 | |
≡ | AMZN - Amazon.com Inc. | 2.30 | Reduce 0.10% | 11,469,200 | $219.39 | $2,516,228,000 | $192.72 | -12.16% | $151.61 | $242.52 | |
≡ | MSFT - Microsoft Corp. | 2.29 | Reduce 0.10% | 5,960,700 | $421.50 | $2,512,435,000 | $378.80 | -10.13% | $376.91 | $465.64 | |
≡ | BK - Bank of New York Mellon Corp. | 2.23 | Reduce 4.63% | 31,876,224 | $76.83 | $2,449,050,000 | $82.71 | 7.65% | $51.27 | $90.34 | |
≡ | OXY - Occidental Petroleum | 2.14 | Reduce 12.42% | 47,546,026 | $49.41 | $2,349,249,000 | $48.83 | -1.17% | $44.47 | $69.95 | |
≡ | GILD - Gilead Sciences | 2.05 | Reduce 0.10% | 24,346,812 | $92.37 | $2,248,915,000 | $111.79 | 21.02% | $59.82 | $119.12 | |
≡ | COF - Capital One Financial | 2.01 | Reduce 7.05% | 12,379,435 | $178.32 | $2,207,501,000 | $173.53 | -2.69% | $126.86 | $210.67 | |
≡ | CVS - CVS Health Corp. | 1.89 | Add 9.16% | 46,043,300 | $44.89 | $2,066,884,000 | $67.14 | 49.57% | $43.01 | $76.49 | |
≡ | BKNG - Booking Holdings Inc. | 1.82 | Reduce 0.10% | 401,330 | $4968.42 | $1,993,976,000 | $4634.24 | -6.73% | $3160.92 | $5326.33 | |
≡ | CMCSA - Comcast Corp. | 1.75 | Add 8.37% | 50,991,994 | $37.53 | $1,913,730,000 | $36.62 | -2.42% | $32.50 | $44.93 | |
≡ | GOOG - Alphabet Inc. CL C | 1.70 | Reduce 32.07% | 9,760,260 | $190.44 | $1,858,744,000 | $156.06 | -18.05% | $147.86 | $208.46 | |
≡ | FIS - Fidelity National Information Services | 1.69 | Reduce 17.11% | 22,982,000 | $80.77 | $1,856,256,000 | $73.65 | -8.82% | $65.47 | $91.08 | |
≡ | GOOGL - Alphabet Inc. | 1.64 | Reduce 0.10% | 9,516,800 | $189.30 | $1,801,530,000 | $154.33 | -18.47% | $146.88 | $206.81 | |
≡ | GE - GE Aerospace | 1.63 | Reduce 0.10% | 10,708,100 | $166.79 | $1,786,004,000 | $199.88 | 19.84% | $132.86 | $214.21 | |
≡ | HUM - Humana Inc. | 1.58 | Add 106.34% | 6,823,200 | $253.71 | $1,731,114,000 | $264.58 | 4.28% | $211.87 | $402.60 | |
≡ | GSK - GSK plc | 1.54 | Reduce 0.10% | 49,998,077 | $33.82 | $1,690,935,000 | $38.74 | 14.55% | $31.37 | $44.38 | |
≡ | CI - Cigna Group | 1.50 | Reduce 0.10% | 5,958,272 | $276.14 | $1,645,317,000 | $325.04 | 17.71% | $260.75 | $367.47 | |
≡ | NSC - Norfolk Southern Corp. | 1.49 | Reduce 0.10% | 6,967,100 | $234.70 | $1,635,178,000 | $230.55 | -1.77% | $203.37 | $276.11 | |
≡ | TMUS - T-Mobile US Inc. | 1.46 | Reduce 0.10% | 7,248,037 | $220.73 | $1,599,859,000 | $264.93 | 20.02% | $156.93 | $276.49 | |
≡ | GS - Goldman Sachs Group | 1.45 | Reduce 30.33% | 2,782,000 | $572.62 | $1,593,029,000 | $543.12 | -5.15% | $378.76 | $668.87 | |
≡ | META - Meta Platforms Inc. | 1.39 | Reduce 0.10% | 2,605,200 | $585.51 | $1,525,371,000 | $576.74 | -1.50% | $412.99 | $740.25 | |
≡ | BUD - Anheuser-Busch InBev | 1.36 | Add 28.65% | 29,879,200 | $50.07 | $1,496,052,000 | $62.04 | 23.91% | $45.94 | $67.49 | |
≡ | WMB - Williams Cos. | 1.32 | Reduce 0.10% | 26,811,057 | $54.12 | $1,451,014,000 | $59.19 | 9.37% | $35.74 | $61.67 | |
≡ | AVTR - Avantor arinc. | 1.28 | Add 46.95% | 66,841,215 | $21.07 | $1,408,344,000 | $16.18 | -23.21% | $15.37 | $28.00 | |
≡ | UNH - United Health Group Inc. | 1.27 | Add 4.43% | 2,757,360 | $505.86 | $1,394,838,000 | $516.04 | 2.01% | $429.51 | $625.65 | |
≡ | BKR - Baker Hughes Co. | 1.25 | Reduce 0.10% | 33,517,666 | $41.02 | $1,374,895,000 | $43.08 | 5.02% | $30.42 | $49.16 | |
≡ | IFF - International Flavors & Fragrances Inc. | 1.24 | Add 15.96% | 16,105,896 | $84.55 | $1,361,754,000 | $76.48 | -9.54% | $76.38 | $105.74 | |
≡ | ZBH - Zimmer Biomet Holdings | 1.21 | Add 15.15% | 12,523,600 | $105.63 | $1,322,868,000 | $112.26 | 6.28% | $97.69 | $130.73 | |
≡ | APD - Air Products & Chemicals | 1.15 | Reduce 0.10% | 4,346,851 | $290.04 | $1,260,761,000 | $292.27 | 0.77% | $223.26 | $341.14 | |
≡ | HLNCF - Haleon plc | 1.13 | Reduce 0.10% | 129,982,361 | $9.54 | $1,240,032,000 | $5.00 | -47.59% | $3.74 | $5.23 | |
≡ | TEL - TE Connectivity plc | 1.05 | Reduce 0.10% | 8,075,875 | $142.97 | $1,154,608,000 | $142.13 | -0.59% | $137.67 | $156.33 | |
≡ | CTSH - Cognizant Technology Solutions | 1.01 | Reduce 0.10% | 14,420,777 | $76.90 | $1,108,958,000 | $75.90 | -1.30% | $63.07 | $90.51 | |
≡ | REGN - Regeneron Pharmaceuticals | 1.01 | Reduce 0.10% | 1,553,785 | $712.33 | $1,106,808,000 | $637.36 | -10.52% | $629.02 | $1209.65 | |
≡ | CSCO - Cisco Systems | 0.97 | Reduce 0.10% | 17,910,387 | $59.20 | $1,060,295,000 | $60.86 | 2.80% | $43.86 | $66.50 | |
≡ | BAX - Baxter International Inc. | 0.91 | Add 14.22% | 34,309,200 | $29.16 | $1,000,456,000 | $33.75 | 15.74% | $28.20 | $42.85 | |
≡ | SBAC - SBA Communications Corp. | 0.91 | Add 388.94% | 4,881,600 | $203.80 | $994,870,000 | $216.84 | 6.40% | $180.17 | $250.22 | |
≡ | BAC - Bank of America Corp. | 0.90 | Reduce 42.01% | 22,463,300 | $43.95 | $987,262,000 | $41.25 | -6.14% | $33.33 | $47.68 | |
≡ | ASHTF - Ashtead Group plc | 0.89 | Add 12.08% | 15,730,954 | $61.85 | $972,991,000 | $70.86 | 14.57% | $55.11 | $76.84 | |
≡ | NVS - Novartis AG | 0.84 | Reduce 0.10% | 9,430,608 | $97.31 | $917,692,000 | $112.57 | 15.68% | $89.14 | $116.72 | |
≡ | D - Dominion Energy Inc. | 0.79 | Reduce 0.10% | 16,070,200 | $53.86 | $865,541,000 | $54.99 | 2.10% | $44.45 | $60.55 | |
≡ | SUI - Sun Communities Inc. | 0.79 | Add 65.24% | 7,043,000 | $122.97 | $866,078,000 | $130.25 | 5.92% | $108.51 | $145.68 | |
≡ | COP - ConocoPhillips | 0.76 | Reduce 0.10% | 8,384,534 | $99.17 | $831,494,000 | $102.37 | 3.23% | $86.81 | $131.16 | |
≡ | GEHC - GE HealthCare Technologies Inc. | 0.76 | Reduce 0.10% | 10,697,266 | $78.18 | $836,312,000 | $80.01 | 2.34% | $74.43 | $94.80 | |
≡ | LYB - LyondellBasell Industries | 0.76 | Add 6.63% | 11,197,363 | $74.27 | $831,628,000 | $69.82 | -5.99% | $69.74 | $100.69 | |
≡ | HPQ - HP Inc. | 0.75 | Reduce 0.10% | 25,303,456 | $32.63 | $825,652,000 | $27.90 | -14.50% | $26.50 | $39.07 | |
≡ | FOXA - Fox Corporation | 0.73 | Reduce 26.69% | 16,497,575 | $48.58 | $801,452,000 | $54.73 | 12.66% | $29.68 | $58.46 | |
≡ | RHHBY - Roche Holding AG ADR | 0.71 | Reduce 0.10% | 22,233,599 | $34.88 | $775,508,000 | $40.64 | 16.51% | $29.20 | $42.43 | |
≡ | CARR - Carrier Global Corp. | 0.67 | Reduce 0.10% | 10,684,079 | $68.26 | $729,295,000 | $63.33 | -7.22% | $52.69 | $82.82 | |
≡ | AEP - American Electric Power | 0.62 | Reduce 0.10% | 7,343,900 | $92.23 | $677,328,000 | $106.96 | 15.97% | $76.22 | $109.52 | |
≡ | ELAN - Elanco Animal Health Inc. | 0.61 | Reduce 0.10% | 55,341,300 | $12.11 | $670,183,000 | $10.41 | -14.04% | $10.03 | $18.80 | |
≡ | INCY - Incyte Corp. | 0.61 | Reduce 0.10% | 9,705,428 | $69.07 | $670,354,000 | $60.60 | -12.26% | $50.35 | $83.95 | |
≡ | BMRN - BioMarin Pharmaceutical Inc. | 0.59 | Add 9.60% | 9,769,625 | $65.73 | $642,157,000 | $71.44 | 8.69% | $60.63 | $94.85 | |
≡ | BMY - Bristol-Myers Squibb | 0.59 | Reduce 0.10% | 11,344,039 | $56.56 | $641,619,000 | $60.02 | 6.12% | $38.18 | $63.33 | |
≡ | COHR - Coherent Corp. | 0.57 | Reduce 0.10% | 6,607,200 | $94.73 | $625,900,000 | $65.73 | -30.61% | $48.78 | $113.60 | |
≡ | CE - Celanese Corp. | 0.56 | Add 99.51% | 8,862,533 | $69.21 | $613,376,000 | $57.20 | -17.35% | $45.94 | $169.42 | |
≡ | TAP - Molson Coors Beverage Co. | 0.56 | Reduce 0.10% | 10,716,625 | $57.32 | $614,277,000 | $60.53 | 5.60% | $48.07 | $67.04 | |
≡ | VFC - V.F. Corp. | 0.54 | Reduce 0.10% | 27,374,300 | $21.46 | $587,452,000 | $15.69 | -26.89% | $10.77 | $28.88 | |
≡ | STT - State Street Corp. | 0.53 | Reduce 20.44% | 5,883,700 | $98.15 | $577,485,000 | $89.04 | -9.28% | $68.41 | $103.00 | |
≡ | AEG - Aegon Ltd | 0.50 | Reduce 0.10% | 93,846,939 | $5.89 | $552,758,000 | $6.61 | 12.22% | $5.45 | $6.82 | |
≡ | ALNY - Alnylam Pharmaceuticals | 0.50 | Reduce 0.10% | 2,315,000 | $235.31 | $544,743,000 | $268.46 | 14.09% | $141.98 | $304.39 | |
≡ | GAP - Gap Inc. | 0.48 | Reduce 0.10% | 22,270,572 | $23.63 | $526,254,000 | $20.42 | -13.58% | $18.54 | $30.14 | |
≡ | UBS - UBS AG | 0.47 | Reduce 0.10% | 16,907,300 | $30.32 | $512,629,000 | $31.56 | 4.09% | $26.01 | $35.84 | |
≡ | GLPI - Gaming and Leisure Properties Inc. | 0.45 | Add 85.25% | 10,141,681 | $48.16 | $488,423,000 | $50.40 | 4.65% | $39.28 | $51.44 | |
≡ | HMC - Honda Motor Co. Ltd. | 0.42 | Reduce 0.10% | 16,032,200 | $28.55 | $457,719,000 | $27.26 | -4.52% | $23.41 | $37.34 | |
≡ | MDT - Medtronic plc | 0.42 | Add 13.09% | 5,743,900 | $79.88 | $458,823,000 | $87.63 | 9.70% | $74.13 | $95.49 | |
≡ | FOX - Fox Corporation CL B | 0.35 | Reduce 0.10% | 8,484,765 | $45.74 | $388,093,000 | $50.52 | 10.45% | $27.29 | $54.72 | |
≡ | NBIX - Neurocrine Biosciences Inc. | 0.26 | Add 195.60% | 2,070,036 | $136.50 | $282,560,000 | $113.16 | -17.10% | $105.18 | $157.98 | |
≡ | BHF - Brighthouse Financial Inc. | 0.22 | Reduce 0.10% | 5,071,619 | $48.04 | $243,641,000 | $57.55 | 19.80% | $40.00 | $64.12 | |
≡ | NWSA - News Corp. | 0.22 | Add 15.27% | 8,951,590 | $27.54 | $246,527,000 | $26.59 | -3.45% | $22.48 | $30.58 | |
≡ | SATS - EchoStar Corp. | 0.19 | Reduce 0.10% | 9,301,409 | $22.90 | $213,002,000 | $24.99 | 9.13% | $12.66 | $32.48 | |
≡ | OXY.WS - Occidental Petroleum WTS | 0.00 | Reduce 0.10% | 9,499,314 | $0.00 | $0 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
Sector % analysis
Health Care | 20.61 | |
Financials | 19.09 | |
Industrials | 11.52 | |
Information Technology | 10.82 | |
Technology | 10.73 | |
Consumer Discretionary | 8.17 | |
Materials | 4.99 | |
Energy | 4.22 | |
Consumer Staples | 3.81 | |
Services | 3.41 | |
Utilities | 1.41 | |
Real Estate | 0.79 | |
Consumer Goods | 0.42 |
Articles & Commentaries
24 May 2024 Dodge & Cox: Emerging Markets - Why and Where
25 Jan 2024 Dodge & Cox Q4 2023 Market Commentary
23 Oct 2023 Dodge & Cox Q3 2023 Market Commentary
24 Jul 2023 Dodge & Cox Q2 2023 Market Commentary
28 Apr 2023 Dodge & Cox: Our Current Thoughts on Financials
28 Apr 2023 Dodge & Cox Q1 2023 Market Commentary
18 Jan 2023 Dodge & Cox Q4 2022 Market Commentary
01 Nov 2022 Dodge & Cox Q3 2022 Commentary
15 Apr 2022 Dodge & Cox Q1 2022 Market Commentary
17 Jan 2022 Dodge & Cox Q4 2021 Market Commentary
15 Oct 2021 Dodge & Cox Q3 2021 Market Commentary
16 Jul 2021 Dodge & Cox Q2 2021 Market Commentary
16 Apr 2021 Dodge & Cox Q1 2021 Market Commentary
16 Jan 2021 Dodge & Cox Q4 2020 Market Commentary
16 Oct 2020 Dodge & Cox Q3 2020 Market Commentary
16 Jul 2020 Dodge & Cox Q2 2020 Market Commentary
23 Apr 2020 Dodge & Cox Q1 2020 Market Commentary
16 Jan 2020 Dodge & Cox Q4 2019 Market Commentary
22 Oct 2019 Dodge & Cox Q3 2019 Market Commentary
16 Jul 2019 Dodge & Cox Q2 2019 Market Commentary
16 Apr 2019 Dodge & Cox Q1 2019 Market Commentary
17 Jan 2019 Dodge & Cox Q4 2018 Commentary
18 Oct 2018 Dodge & Cox Q3 2018 Commentary
17 Jul 2018 Dodge & Cox Q2 2018 Commentary
18 Apr 2018 Dodge & Cox Q1 2018 Commentary